Amgen's new drug MariTide shows promise in obesity treatment, with participants losing up to 16% body weight in a year with monthly shots.

Amgen (NASDAQ:AMGN) today announced full results from Part 1 of the Phase 2 study of MariTide (maridebart cafraglutide, formerly AMG 133), a long-acting, peptide-antibody conjugate subcutaneously ...

Healthcare FIFA funded study to research potential link between ACL tears and a woman's monthly period: HealthLink ...

More than one third of children in Ireland see sexual images online at least monthly, according to an assessment of research on internet safety.

NEW YORK, June 02, 2025--E*TRADE from Morgan Stanley today released the data from its monthly sector rotation study, based on the E*TRADE customer notional net percentage buy/sell behavior for ...

E*TRADE from Morgan Stanley today released the data from its monthly sector rotation study, based on the E*TRADE customer notional net percentage buy/sell behavior for stocks that comprise the S&P ...

Excel template that automatically logs timed values, calculates a 95% confidence interval around your average, and the number of samples required to achieve a desired confidence interval.

Ascletis Announces First Participants Dosed in a U.S. Clinical Study Combining Adipose-Targeted, Once-Monthly Injectable Small Molecule THRβ Agonist, ASC47, and Semaglutide for the Treatment of ...

A study released Thursday found that women who consumed at least one sugar-sweetened beverage daily had a nearly five times greater chance of developing oral cancer than those who avoided sugary ...